درباره این اپیزود
Guest: Andrew Mastro, MS, PA-C
In atopic dermatitis, the timing of itch relief and visible skin improvement can make all the difference in how patients perceive their response to topical JAK inhibitor therapy. Andrew Mastro, physician assistant at the Illinois Dermatology Institute and DeNova Research in Chicago, shares his approach to translating clinical trial data into practical counseling strategies, setting meaningful treatment milestones, and timing follow-up visits to capture early wins and address emerging challenges.
انگلیسی
ایالات متحده آمریکا
در این اپیزود
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی DermConsult را جستجو کن.
قسمت های دیگر در این پادکست
Host: Alexandria May, PharmD, BCPS
Guest: Naiem T. Issa, MD, PhD, FAAD
Guest: Allison Truong, MD
Atopic dermatitis affecting the face, neck, hands, genital, and intertriginous areas can have a profound impact on patients' quality of life, even when overall disease involvement app…
Host: Alexandria May, PharmD, BCPS
Guest: Naiem T. Issa, MD, PhD, FAAD
Inflammatory dermatoses don't always follow the rules. When clinical features overlap or presentations fall outside familiar patterns, reaching the right diagnosis requires a thoughtful, systematic approach. In th…
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Christina Kraus, MD
Guest: Jill Krapf, MD
Vulvar lichen sclerosus sits at the intersection of dermatology and gynecology, making coordinated care essential. In this expert-led conversation, Dr. Charles Turck sits down with Dr. Chris…
Host: Shelina Ramnarine, PhD
Guest: Christopher Bunick, MD, PhD, FAAD
Hand atopic dermatitis and other subtypes of chronic hand eczema can present similarly, but differences in their underlying drivers can have important implications for diagnosis and treatment. Review which clinical…
Guest: Peter Lio, MD
Atopic dermatitis may look similar across patients, but could distinct underlying mechanisms call for more personalized treatment approaches? Dr. Peter Lio explores how emerging biomarkers could help us better understand individual disease drivers, …
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به ReachMD است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم